A.O.U Maggiore della Carità

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Lung cancer1 trial
• Myelodysplastic syndromes1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 22 trials
• Phase 31 trial
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Associazione Qol-One1 trial
• Fondazione Ricerca Traslazionale1 trial
• IRCCS Istituto Nazionale Tumori Fondazione Pascale1 trial
• Queen Mary University Of London1 trial

Running trials

• Recruiting

  Eltrombopag for the treatment of thrombocytopenia due to low - and intermediate risk myelodysplastic syndromes.

  NCT02912208· Phase 2· Associazione Qol-One· Source

• Recruiting

  Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer (IMPROVE-2 trial)

  2023-509551-14-00· Phase 3· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Source

• Recruiting

  The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study

  2022-502021-18-00· Phase 4· Queen Mary University Of London· Source

• Recruiting

  A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) sequence in advanced or metastatic non-small-cell lung cancer (NSCLC) harboring EGFR mutations

  NCT04811001· Phase 2· Fondazione Ricerca Traslazionale· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Rheumatoid arthritis1 recruiting